For US residents only.

Financial Resources

TAFINLAR + MEKINIST

Novartis Oncology Universal Co-Pay Program

Novartis Oncology offers access to information about financial assistance for almost all Novartis Oncology products. You may be eligible for immediate co-pay savings on your next prescription:

  • Commercially insured patients pay $10 per month per TAFINLAR® (dabrafenib) and MEKINIST® (trametinib) or $20 per month for both TAFINLAR and MEKINIST
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year

Patient Assistance Now Oncology

Novartis Oncology is committed to helping you get the medicines you need. Getting access to medications can sometimes be difficult or confusing. Patient Assistance Now Oncology (PANO) offers tools and support designed specifically to help make that process easier.

Support for patients includes:

  • Help you understand your insurance coverage and financial responsibilities through the insurance verification process
  • Help you identify/determine pharmacies covered by your plan
  • Provide insurance and Medicare education
  • Provide information about financial assistance that may be available
  • Patient Support Counselors who are able to provide information in over 160 languages
  • One single point of contact to help guide you through getting access to the medicine prescribed by your doctor

To learn more, call 1-800-282-7630.

Free 30-Day Trial

Eligible patients can receive a one-time, per-dose, free 30-day supply of TAFINLAR and MEKINIST for a US Food and Drug Administration-approved indication. Your supply will be shipped directly to you so you can get started with treatment immediately.

Ask your health care provider about the TAFINLAR and MEKINIST Free 30-Day Trial program.